FDA Inspection 1210944 — Actavis Pharma Development Centre Private Ltd
The FDA completed an inspection of Actavis Pharma Development Centre Private Ltd on Jul 11, 2023 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chennai (India)